Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
- 1 April 2008
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (4) , 351-356
- https://doi.org/10.1016/j.ajog.2008.01.005
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistanceInternational Journal of Gynecologic Cancer, 2008
- The distal fallopian tube: a new model for pelvic serous carcinogenesisCurrent Opinion in Obstetrics and Gynecology, 2007
- BEAMing: single-molecule PCR on microparticles in water-in-oil emulsionsNature Methods, 2006
- Molecular genetic evidence that endometriosis is a precursor of ovarian cancerInternational Journal of Cancer, 2006
- BEAMing up for detection and quantification of rare sequence variantsNature Methods, 2006
- Cancer genes and the pathways they controlNature Medicine, 2004
- K-ras alterations in Danish ovarian tumour patients.Gynecologic Oncology, 2003
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerThe Journal of Pathology, 2001
- Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian CancersThe American Journal of Pathology, 2000
- Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumoursThe Journal of Pathology, 1997